These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35882695)

  • 1. Soluble E-Cadherin as a Potential Biomarker in Hereditary Diffuse Gastric Cancer Syndrome.
    Teke ME; Gamble LA; Samaranayake SG; Green BL; Saif A; Hernandez JM; Davis JL
    Ann Surg Oncol; 2022 Dec; 29(13):7955-7957. PubMed ID: 35882695
    [No Abstract]   [Full Text] [Related]  

  • 2. Hereditary diffuse gastric cancer associated with E-cadherin mutation: penetrance after all.
    Gaya DR; Stuart RC; Going JJ; Stanley AJ
    Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1249-51. PubMed ID: 18989144
    [No Abstract]   [Full Text] [Related]  

  • 3. Cate's Story: Hereditary Diffuse Gastric Cancer.
    Rogers M
    Clin J Oncol Nurs; 2016 Aug; 20(4):443-5. PubMed ID: 27441520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer.
    Guilford PJ; Hopkins JB; Grady WM; Markowitz SD; Willis J; Lynch H; Rajput A; Wiesner GL; Lindor NM; Burgart LJ; Toro TT; Lee D; Limacher JM; Shaw DW; Findlay MP; Reeve AE
    Hum Mutat; 1999; 14(3):249-55. PubMed ID: 10477433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric cancer: new genetic developments.
    Lynch HT; Grady W; Suriano G; Huntsman D
    J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary gastric cancer: what's new? Update 2013-2018.
    van der Post RS; Oliveira C; Guilford P; Carneiro F
    Fam Cancer; 2019 Jul; 18(3):363-367. PubMed ID: 30989426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E-cadherin germline mutations in Māori population.
    De Scalzi AM; Bonanni B; Galimberti V; Veronesi P; Pravettoni G; Corso G
    Future Oncol; 2019 Apr; 15(12):1291-1294. PubMed ID: 30977389
    [No Abstract]   [Full Text] [Related]  

  • 8. Hereditary diffuse gastric cancer (HDGC). An overview.
    Taja-Chayeb L; Vidal-Millán S; Trejo-Becerril C; Pérez-Cárdenas E; Chávez-Blanco A; Domínguez-Gómez G; González-Fierro A; Romo-Pérez A; Dueñas-González A
    Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101820. PubMed ID: 34656755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic mutations identified for hereditary diffuse gastric cancer.
    Peek R; Reddy KR
    Gastroenterology; 2007 Aug; 133(2):379-80. PubMed ID: 17681152
    [No Abstract]   [Full Text] [Related]  

  • 10. E-cadherin alterations in hereditary disorders with emphasis on hereditary diffuse gastric cancer.
    Oliveira C; Pinheiro H; Figueiredo J; Seruca R; Carneiro F
    Prog Mol Biol Transl Sci; 2013; 116():337-59. PubMed ID: 23481202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of E-cadherin associated hereditary diffuse gastric cancer.
    Fitzgerald RC; Caldas C
    Gut; 2004 Jun; 53(6):775-8. PubMed ID: 15138199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic background and clinical features of hereditary diffuse gastric cancer].
    Vasas P; Bijendra P
    Orv Hetil; 2011 Jul; 152(28):1105-9. PubMed ID: 21737393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations.
    Huntsman DG; Carneiro F; Lewis FR; MacLeod PM; Hayashi A; Monaghan KG; Maung R; Seruca R; Jackson CE; Caldas C
    N Engl J Med; 2001 Jun; 344(25):1904-9. PubMed ID: 11419427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary diffuse gastric cancer: more answers or more questions?
    Grady WM; Peek RM
    Gastroenterology; 2002 Mar; 122(3):830-1; discussion 831-2. PubMed ID: 11875020
    [No Abstract]   [Full Text] [Related]  

  • 15. Pancreatic ductal adenocarcinoma in hereditary diffuse gastric cancer. A case report.
    Ottenhof NA; de Wilde RF; Morsink FH; de Leng WW; Ausems MG; Morreau H; van Hillegersberg R; Offerhaus GJ; Milne AN
    Hum Pathol; 2012 Mar; 43(3):457-61. PubMed ID: 21992816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E-cadherin germline mutations and risk of gastric cancer.
    McColl KE; El-Omar E
    Gastroenterology; 2002 Oct; 123(4):1406; author reply 1406-7. PubMed ID: 12360507
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening E-cadherin germline mutations in Italian patients with familial diffuse gastric cancer: an analysis in the District of Urbino, Region Marche, Central Italy.
    Graziano F; Ruzzo AM; Bearzi I; Testa E; Lai V; Magnani M
    Tumori; 2003; 89(3):255-8. PubMed ID: 12908778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [From gene to disease; E-cadherin and hereditary diffuse gastric cancer].
    de Bruin JH; Ligtenberg MJ; Nagengast FM; van Krieken JH
    Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2474-7. PubMed ID: 14708213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice.
    Guilford P; Humar B; Blair V
    Gastric Cancer; 2010 Mar; 13(1):1-10. PubMed ID: 20373070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary diffuse gastric cancer and E-cadherin: description of the first germline mutation in an Italian family.
    Roviello F; Corso G; Pedrazzani C; Marrelli D; De Falco G; Berardi A; Garosi L; Suriano G; Vindigni C; De Stefano A; Leoncini L; Seruca R; Pinto E
    Eur J Surg Oncol; 2007 May; 33(4):448-51. PubMed ID: 17126523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.